Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
BioLum Sciences
AddedFeb 16, 2024
UpdatedJun 18, 2026
BioLum Sciences

BioLum Sciences

Angel

BioLum Sciences develops medical devices for personalized treatments, using advanced bioanalytical chemistry to measure biomarkers in breath and blood for chronic disease management.

HQ
Dallas, TX, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

BioLum Sciences, founded with a mission to revolutionize chronic disease management, specializes in bioanalytical chemistry and medical device development. The company focuses on creating advanced chemical systems to measure biomarkers in exhaled breath condensate and blood samples. Their core analysis platform and chemiluminescent chemistry enable pharmaceutical researchers and clinicians to develop and personalize treatments for conditions such as asthma, COPD, and hypertension.

Notable figures affiliated with BioLum Sciences include leading experts in bioanalytical chemistry and medical device innovation. The company has garnered attention from prominent investors in the healthcare and biotechnology sectors. Key achievements include the successful development of novel assays and diagnostic tools that enhance drug discovery and early disease detection. BioLum Sciences' impact lies in its ability to provide superior detection of reactive oxygen, nitrogen, and sulfur species, thereby propelling critical therapies and improving patient outcomes.

BioLum Sciences - Similar Companies

Biometry logo

Biometry

mybiometry.com

eGlint logo

eGlint

Luminostics logo

Luminostics

eLum Technologies logo

eLum Technologies

Breath Diagnostics logo

Breath Diagnostics

EmitBio logo

EmitBio

emitbio.com

Nano Mobile Healthcare logo

Nano Mobile Healthcare

LumiThera logo

LumiThera

lumithera.com

Biophysical logo

Biophysical

i-Lumen Scientific logo

i-Lumen Scientific

i-lumen.com

Boydsense logo

Boydsense

boydsense.com

BioAnalytics logo

BioAnalytics

Amplified Sciences logo

Amplified Sciences

Lumen Biomedical logo

Lumen Biomedical

lumenbio.com

LumaCyte logo

LumaCyte

lumacyte.com

BioLum Sciences - Quick Facts

Who are BioLum Sciences' competitors?

Companies similar to BioLum Sciences include Biometry, eGlint, Luminostics and eLum Technologies.

When was BioLum Sciences founded?

BioLum Sciences was founded in 2015.

Where is BioLum Sciences' headquarters located?

BioLum Sciences' headquarters is located in Dallas, TX, US.

When was BioLum Sciences' last funding round?

BioLum Sciences' most recent funding round was for $251.9k (USD) in December 2021.

How much has BioLum Sciences raised to-date?

As of Dec 22, 2021, BioLum Sciences has raised a total of $1M (USD).

How many employees does BioLum Sciences have?

BioLum Sciences has 5 employees as of Feb 4, 2024.

BioLum Sciences - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Analytics
Geographic Exposure
  • United States
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Consulting
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 1 more industry code
NAICS
  • 623000Nursing and Residential Care Facilities